Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine R Broglio

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|November 12, 2009
Detecting an overall survival benefit that is derived from progression-free survivalKristine R Broglio, Donald A Berry
Journal of Clinical Epidemiology|July 16, 2013
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticusJason T Connor, Jordan J Elm, Kristine R Broglio, et al.
Trials|March 11, 2014
Predicting clinical trial results based on announcements of interim analysesKristine R Broglio, David N Stivers, Donald A Berry
Cancer|October 12, 2004
Adult glioma incidence trends in the United States, 1977-2000Kenneth R Hess, Kristine R Broglio, Melissa L Bondy
Journal of Biopharmaceutical Statistics|January 22, 2013
Combining risk difference and risk ratio in noninferiority trials of safetyKristine R Broglio, Jason T Connor, Scott M Berry
Cancer Investigation|April 8, 2011
Addressing the incremental benefit of histamine dihydrochloride when added to interleukin-2 in treating acute myeloid leukemia: a Bayesian meta-analysisScott M Berry, Kristine R Broglio, Donald A Berry
Journal of Biopharmaceutical Statistics|April 5, 2014
Not too big, not too small: a goldilocks approach to sample size selectionKristine R Broglio, Jason T Connor, Scott M Berry
Contemporary Clinical Trials|July 15, 2015
Bayesian dose escalation in oncology with sharing of information between patient populationsKristine R Broglio, Larissa Sandalic, Tina Albertson, et al.
Clinical Trials (London, England)|August 29, 2013
Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trialsScott M Berry, Kristine R Broglio, Susan Groshen, et al.
Drug Discovery Today|August 4, 2024
Multidisciplinary considerations for implementing Bayesian borrowing in basket trialsKristine R Broglio, Jenny E Blau, Elizabeth A Pilling, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|November 12, 2009
Detecting an overall survival benefit that is derived from progression-free survivalKristine R Broglio, Donald A Berry
Journal of Clinical Epidemiology|July 16, 2013
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticusJason T Connor, Jordan J Elm, Kristine R Broglio, et al.
Trials|March 11, 2014
Predicting clinical trial results based on announcements of interim analysesKristine R Broglio, David N Stivers, Donald A Berry
Cancer|October 12, 2004
Adult glioma incidence trends in the United States, 1977-2000Kenneth R Hess, Kristine R Broglio, Melissa L Bondy
Journal of Biopharmaceutical Statistics|January 22, 2013
Combining risk difference and risk ratio in noninferiority trials of safetyKristine R Broglio, Jason T Connor, Scott M Berry
Cancer Investigation|April 8, 2011
Addressing the incremental benefit of histamine dihydrochloride when added to interleukin-2 in treating acute myeloid leukemia: a Bayesian meta-analysisScott M Berry, Kristine R Broglio, Donald A Berry
Journal of Biopharmaceutical Statistics|April 5, 2014
Not too big, not too small: a goldilocks approach to sample size selectionKristine R Broglio, Jason T Connor, Scott M Berry
Contemporary Clinical Trials|July 15, 2015
Bayesian dose escalation in oncology with sharing of information between patient populationsKristine R Broglio, Larissa Sandalic, Tina Albertson, et al.
Clinical Trials (London, England)|August 29, 2013
Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trialsScott M Berry, Kristine R Broglio, Susan Groshen, et al.
Drug Discovery Today|August 4, 2024
Multidisciplinary considerations for implementing Bayesian borrowing in basket trialsKristine R Broglio, Jenny E Blau, Elizabeth A Pilling, et al.
Pageof 4